TABLE 1.
Group A N = 16 | Group B N = 19 | Test of significance | |||||
---|---|---|---|---|---|---|---|
Sex | |||||||
Male: N = 15 (43%) | 7 (44%) | 8 (42%) | X 2 = 0.0667 | ||||
Female: N = 20 (57%) | 9 (56%) | 11 (58%) | P = 0.7963 | ||||
Severity | |||||||
Mild | 2 | 1 | W = 194 | ||||
Moderate | 5 | 2 | P = 0.0827 | ||||
Severe | 9 | 16 | |||||
Comorbidities | |||||||
Diabetes mellitus (DM) | 7 | 5 | X 2 = 0.33 | ||||
P = 0.56 | |||||||
Hypertension (HTN) | 7 | 5 | X 2 = 0.33 | ||||
P = 0.56 | |||||||
DM + HTN | 4 | 3 | X 2 = 0 | ||||
P = 1 | |||||||
Bronchial asthma | 2 | 2 | X 2 = 0 | ||||
P = 1 | |||||||
Mean | ±SD | Standard error | Mean | ±SD | Standard error | Test of Sig. | |
Age/years | 35.73 | 27.61 | 7.13 | 18.68 | 22.67 | 5.20 | W = 85 |
P = 0.0476 | |||||||
TLC (thousands/cmm3) | 9.93 | 4.39 | 1.098 | 14.14 | 18.53 | 4.25 | W = 152 |
P = 1 | |||||||
Hemoglobin (g/dl) | 10.23 | 1.76 | 0.44 | 10.45 | 2.32 | 0.534 | W = 130 |
P = 0.47 | |||||||
Platelets (thousands/cmm) | 249.06 | 133.21 | 30.56 | 253.36 | 85.66 | 21.41 | T test = 0.1153 |
0.9089 | |||||||
Ferritin (mg/L) | 394.71 | 245.47 | 61.36 | 334.07 | 401.67 | 92.15 | W = 110.5 |
P = 0.1744 | |||||||
Lactate dehydrogenase (LDH) (U/L) | 412.71 | 188.47 | 47.11 | 395.68 | 189.68 | 43.51 | t test = -0.266 |
P = 0.7923 | |||||||
D-dimer(mg/L) | 1.40 | 1.40 | 0.35 | 2.84 | 5.54 | 1.27 | W = 131 |
P = 0.497 |
Total leukocyte count (TLC) (thousands/cmm3), hemoglobin (g/dl), platelets (thousands/cmm3), ferritin (mg/L), and lactate dehydrogenase (LDH) (U/L). X 2 : Chi-square test, W: Mann–Whitney U test, P: p-value, and T-test: Student t-test.